Andrea Cavazzoni

Assistant professor

University of Parma

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Andrea Cavazzoni is an Assistant Professor at the University of Parma, Italy. His research focuses on the molecular and cellular mechanisms of non-small cell lung cancer (NSCLC), including the roles of cytokines and tumor signaling pathways. Recent publications highlight his work on PD-L1 expression, therapeutic strategies involving cytokine modulation, and the efficacy of CDK4/6 inhibition in various cancer types.

Articles (9)

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (7)

Massimo Corradi

University of Parma

ITALY

View details

LUCA MORELLI

Professore Associato in Chirurgia Generale

University of Pisa

ITALY

View details

Silvia La Monica

University of Parma

ITALY

View details

Fabio Gelsomino

ITALY

View details

Valeria Barili

University of Parma

ITALY

View details

Rosanna Piccirillo

Head of the Neuromuscular Disfunctions Laboratory

Istituto di Ricerche Farmacologiche Mario Negri

ITALY

View details

Marcello Tiseo

University of Parma

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrea Cavazzoni

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Correction: Cavazzoni et al. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. <i>Cancers</i> 2020, <i>12</i>, 666

PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC)

Role of Cytokines and Other Soluble Factors in Tumor Development: Rationale for New Therapeutic Strategies

Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics

CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells

It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer

Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC

Efficacy of the CDK4/6 Dual Inhibitor Abemaciclib in EGFR-Mutated NSCLC Cell Lines with Different Resistance Mechanisms to Osimertinib

Dual Inhibition of CDK4/6 and PI3K/AKT/mTOR Signaling Impairs Energy Metabolism in MPM Cancer Cells

Collaborators (7)

Massimo Corradi

LUCA MORELLI

Silvia La Monica

Fabio Gelsomino

Valeria Barili

Rosanna Piccirillo

Marcello Tiseo

Make your next move.